Toronto, Canada — April 13 — The Structural Genomics Consortium (SGC) today announced that it will expand its leadership team to help accelerate the next phase of Target 2035, a global effort to develop a pharmacological modulator for every human protein by 2035.
A new international network of machine learning researchers, computational chemists, and data scientists. Membership is free and provides access to curated datasets for model testing and benchmarking.
Target 2035 collaborates with BEACON, the new benchmarking super-consortium comprising CACHE, DREAM, CASP, OpenADMET, to provide a platform for computational scientists to benchmark hit-finding algorithms in real world settings, with experimental testing of model predictions.
Professional Expertise: Research and Research Support
Department: School of Life & Medical Sciences (B02)
Location: London
Working Pattern: Full time
Salary: £54,931-£64,644
Contract Type: Fixed-term
Working Type: On site
Closing Date: 23-Apr-2026
Professional Expertise: Research and Research Support
Department: School of Life & Medical Sciences (B02)
Location: London
Working Pattern: Full time
Salary: £43,981-£52,586
Contract Type: Fixed-term
Working Type: On site
Closing Date: 23-Apr-2026
Frankfurt, Germany – April 7, 2026 — PREVENT (Precision REproductive and contraceptiVE target discovery NeTwork), a new multidisciplinary initiative focused on expanding non-hormonal contraceptive strategies, has officially launched. The program brings together expertise across reproductive biology, chemical biology, structural biology, and medicinal chemistry to identify and validate novel targets involved in fertility.
In March 2026, the first MAINFRAME Symposium brought together more than 180 researchers from academia and industry in Barcelona, marking a defining moment for a rapidly emerging field. What began just over a year ago as an idea to create an open, global community focused on machine learning for drug discovery has quickly evolved into a growing international network now spanning more than 250 members across 45+ countries.
A global higher education leader in innovative teaching, research and public service, the University of North Carolina at Chapel Hill consistently ranks as one of the nation’s top public universities and is among is the top ten research universities in the nation for federal research expenditures as well as for federally funded social and behavioral sciences research and development.
Location: Toronto, Ontario, Canada (Split between The Hospital for Sick Children and the Structural Genomics Consortium).
Term: Multi-year project (Estimated 2026-2028).
Supervision: Dr. Michal Koziarski (SickKids/UofT) and Dr. Matthieu Schapira (SGC/UofT).
Industry partnership: A Senior Scientific Director, Computational Drug Discovery from a large pharmaceutical company agreed to act as Industry Mentor.
Supervisor(s): Position 1: Benjamin Sanchez-Lengeling (University of Toronto), Pablo Meyer (IBM Research) and Gustavo Stolovitzky (NYU Langone) | Position 2: John Moult (University of Maryland) and Matthieu Schapira (SGC)
Program: Mitacs Accelerate – Target 2035 Fellows
Location: Toronto, Canada